Turn opportunity into commercial reality.
Quanthym helps companies validate markets, build commercial traction, and create the customers, partnerships and proof needed to grow.
You don’t need another strategy deck. You need to know what will actually work.
Companies usually come to Quanthym when the opportunity is clear, but the path isn’t. A new market. A promising product. Early traction that isn’t scaling. A sales motion that still depends on the founder. Quanthym helps identify the commercial constraint, test the assumptions and turn strategy into measurable market evidence.
Great products can still get stuck.
The distance between what a company has built and what the market is willing to buy is rarely one problem. Quanthym looks for the constraint preventing the next stage of commercial growth.
Market Gap
The opportunity looks real, but where to start, who to target and how to enter remain unclear.
Proof Gap
Buyers are interested, but the evidence needed to remove perceived risk hasn’t been built yet.
Access Gap
You know who should buy, but getting into the right rooms and conversations remains difficult.
Execution Gap
The strategy exists, but there aren’t enough commercial resources to turn it into results.
Credibility Gap
The market is being asked to believe more than the company has yet been able to prove.
Strategy, proof and execution around the constraint that matters.
Enter a Market
Validate the opportunity before committing significant capital, headcount or infrastructure.
- Market validation
- U.S. entry strategy
- ICP and buyer discovery
- Competitive positioning
- Initial commercial foothold
Create Traction
Build the customers, partnerships and proof that make the next commercial conversation easier.
- Strategic business development
- Alpha and pilot cohorts
- Partnership development
- Proof assets
- Strategic sales
Build the Engine
Turn early commercial wins into a more repeatable, scalable path to growth.
- Go-to-market architecture
- Sales enablement
- Commercial infrastructure
- Decision rules and metrics
- Expansion strategy
Don’t just enter the United States. Build a U.S. business.
Quanthym works with international companies ready to validate, commercialize and grow in the United States.
Validate
Market, ICP, buyer conversations, competitive reality, positioning and commercial barriers.
Prove
Alpha cohorts, initial customers, partnerships, messaging and proof assets that reduce market risk.
Build
Pipeline, sales motion, strategic partnerships and the operating roadmap for the U.S. business.
Built from inside the work, not outside the room.
Strategy is more useful when you’ve had to execute it.
Quanthym founder Gary Burtka has spent his career building markets, launching companies, scaling revenue organizations and creating commercial traction across technology, advertising, payments and emerging businesses.
Quanthym brings that operator perspective to companies facing high-stakes commercialization decisions where research alone isn’t enough.
Complete
How do you introduce biometric payments to a market that has never used them?
Quanthym founder Gary Burtka led the launch and market validation of iris + face biometric payments in North America.
The objective wasn’t simply introducing technology. It was creating the users, transactions, operating experience and market proof needed to demonstrate that an unfamiliar payment experience could work in a new market.
The engagement should fit the commercial problem.
Quanthym works selectively with companies where operator-level involvement can materially change the outcome.
Strategic Advisory
Ongoing operator-level guidance for founders and leadership teams navigating commercialization, growth and market-entry decisions.
Focused Commercialization
Defined projects around market validation, GTM strategy, proof creation, partnerships or strategic business development.
Market Building
Deeper involvement for companies establishing a new market, commercial operation or U.S. business from the ground up.
What could your business become if the market started saying yes?
If you’re entering a new market, commercializing something new or trying to turn early traction into meaningful growth, let’s talk about the constraint standing between where you are and where you’re trying to go.
Start the Conversation →